Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating.

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for KLA in a note issued to investors on Friday, January 31st. Cantor Fitzgerald analyst C. Muse ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

TMC the metals company Inc (TMC) stock saw a modest uptick, ending the day at $1.78 which represents a slight increase of $0.15 or 9.20% from the prior close of $1.63. The stock opened at $1.58 and ...

The 20-foot wide mansion was built in 1869 along with three others on East 74th Street, and was significantly redesigned in ...

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

U.S. President Donald Trump signed an executive order Monday afternoon charging the Treasury and Commerce Departments with ...

In a report released yesterday, Brett Knoblauch from Cantor Fitzgerald maintained a Buy rating on Cipher Mining (CIFR – Research Report), with ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...